We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App




New Generation Glucose Hospital Meter System Ensures Accurate, Interference-Free and Safe Use

By LabMedica International staff writers
Posted on 02 Apr 2024
Print article
Image: The new generation StatStrip Glucose Hospital Meter has obtained FDA 510k clearance (Photo courtesy of Nova Biomedical)
Image: The new generation StatStrip Glucose Hospital Meter has obtained FDA 510k clearance (Photo courtesy of Nova Biomedical)

A new generation glucose hospital meter system now comes with several features that make hospital glucose testing easier and more secure while continuing to offer accuracy, freedom from interference, and FDA clearance for use with critically ill patients.

Nova Biomedical (Waltham, MA, USA) has introduced the New Generation StatStrip Glucose Hospital Meter System to the U.S. market. This system continues to utilize the only FDA-cleared test strip for glucose testing of critically ill patients. More than 200 published clinical studies validate StatStrip's accurate and reliable results, highlighting its ability to eliminate interference from a wide range of medications (over 8,000 tested) and the complex physiological conditions often encountered among patients in intensive care settings with complex medical conditions and drug regimens. The New Generation StatStrip enhances bedside glucose testing with several key advancements, including a transition to a Linux® operating system for improved cybersecurity against viruses and other malware, and extension of its hematocrit range to 5-75%.

The New Generation StatStrip now comes with RFID technology, an illuminated barcode scanner, and touchscreen keyboard entry for easier submission of operator ID and patient ID. It also features a wireless meter for faster, easier, and safer charging. The battery is charged in the meter’s sealed compartment, with the charger automatically shutting off when the meter becomes fully charged. Additionally, StatStrip’s new meter casing has been built using a unique soft-touch over-molding material that can withstand rough use and exposure to harsh disinfecting agents.

“We are proud to now offer our StatStrip New Generation platform for glucose testing,” said Rick Rollins, StatStrip Product Manager. “The new meter gives current StatStrip users and non-users a clear upgrade for easier hospital glucose testing while ensuring accurate, interference- free, and safe use with critically ill patients.”

Related Links:
Nova Biomedical

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.